p300 Degradation by the p53‐SIAH1 Axis Relieves TBK1 Acetylation to Enhance Innate Antiviral Immunity
Advanced Science · 2026
DOI: 10.1002/advs.76101 ↗At a glance
Journal article in Advanced Science, 2026. Written by Huidi Yu and 6 co-authors. Institution: College of Veterinary Medicine, Institute of Comparative Medicine, Yangzhou University, Yangzhou, Jiangsu, China. Major MEDLINE topics: Immunity, Innate, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Ubiquitin-Protein Ligases. Cited 1 times so far (Crossref); 56 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation, Paragon Philanthropy, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (original language)
p300 is an acetyltransferase that regulates gene expression by acetylating histones and transactivating some transcription factors such as nuclear Factor Kappa B (NF‐κB) and interferon regulatory factor 3 (IRF3). p53 is an interferon (IFN)‐inducible tumor suppressor that enhances antiviral responses. How p300 and p53 precisely regulate innate antiviral immunity remains incompletely understood. Herein, we report that conditional p300 knockout in alveolar epithelial cells does not suppress but rather enhances antiviral responses in mice infected with vesicular stomatitis virus (VSV) and herpes simplex virus (HSV‐1). In vitro investigation reveals that A‐485, a p300‐specific inhibitor, and p300 knockdown suppress virus replication but promote IFN‐β production in a variety of cell types by enhancing (TANK‐binding kinase 1) TBK1 and IRF3 phosphorylation. p300 binds TBK1 and acetylates two lysine residues at 241 and 692 to block its activation. p300 expression is downregulated by viral infection in a p53‐dependent manner. Mechanistically, viral infection increases the levels of p53, which leads to the upregulation of the seven in absentia homolog 1 (SIAH1) E3 ubiquitin ligase. SIAH1 induces p300 K48‐linked polyubiquitination and subsequent proteasomal degradation. Consistently, p53 knockout inhibits, whereas SIAH overexpression enhances antiviral responses. Taken together, our study identifies p300 as an acetyltransferase that suppresses innate immunity by acetylating TBK1, and demonstrates that the p53‐SIAH1 axis downregulates p300 to sustain antiviral responses.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Veterinary Medicine, Institute of Comparative Medicine, Yangzhou University, Yangzhou, Jiangsu, China.
- College of Bioscience and Biotechnology, Yangzhou University, Yangzhou, Jiangsu, China.
- Jiangsu Co-innovation Center For Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, Jiangsu, China.
Funding
- National Natural Science Foundation
- Paragon Philanthropy
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Postgraduate Research & Practice Innovation Program of Jiangsu Province (Yangzhou University)
Cite
APA
Yu, H., Zhan, Z., Pan, X., Zhang, X., Liu, P., Sun, J., & Xu, X. (2026). p300 Degradation by the p53‐SIAH1 Axis Relieves TBK1 Acetylation to Enhance Innate Antiviral Immunity. Advanced Science. https://doi.org/10.1002/advs.76101
Vancouver
Yu H, Zhan Z, Pan X, Zhang X, Liu P, Sun J, et al. p300 Degradation by the p53‐SIAH1 Axis Relieves TBK1 Acetylation to Enhance Innate Antiviral Immunity. Advanced Science. 2026. doi:10.1002/advs.76101
BibTeX
@article{Yu2026,
author = {Yu, Huidi and Zhan, Zhihao and Pan, Xiaoxiang and Zhang, Xinyue and Liu, Penggang and Sun, Jing and Xu, Xiulong},
title = {p300 Degradation by the p53‐SIAH1 Axis Relieves TBK1 Acetylation to Enhance Innate Antiviral Immunity},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76101}
}
EUVIMED